Jove
Visualize
Contact Us

Related Experiment Videos

[Carbamazepine and aggressive behavior: a review].

F Thibaut1, L Colonna

  • 1C.H.S. du Rouvray, 4, rue Paul Eluard, 76301 Sotteville-les-Rouen.

L'Encephale
|November 1, 1993
PubMed
Summary

Carbamazepine effectively controls aggressive behavior in epilepsy patients and may benefit those with other diagnoses, like schizophrenia. Monitoring blood counts and liver function is essential due to rare risks of bone marrow suppression and hepatotoxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of Baricitinib in Alopecia Areata Patients With a Current Episode Lasting Longer Than 8 Years: An Italian Multicenter Real-Life Experience in the Lazio Region.

International journal of dermatology·2025
Same author

Chemical sex (chemsex) in a population of French university students.

Dialogues in clinical neuroscience·2022
Same author

Antipsychotic drug dose in real-life settings results from a Nationwide Cohort Study.

European archives of psychiatry and clinical neuroscience·2021
Same author

[The concept of paedophilia. Part 2: Etiologies, forensic aspects and therapeutic options].

Revue medicale de Liege·2021
Same author

[The concept of paedophilia. Part 1 : Historical background and nosology].

Revue medicale de Liege·2021
Same author

[Psychopathological consequences of confinement].

L'Encephale·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neurology
  • Psychiatry
  • Pharmacology

Context:

  • Carbamazepine, an established anticonvulsant, is increasingly recognized for managing aggressive behavior.
  • Aggression is a significant concern in both epileptic and non-epileptic populations.

Purpose:

  • To evaluate the efficacy of carbamazepine in controlling aggressive behavior.
  • To explore its potential use in diverse patient groups, including those with schizophrenia.
  • To identify optimal dosing and monitor for adverse effects.

Summary:

  • Carbamazepine demonstrates effectiveness in managing aggressive outbursts, particularly in epileptic individuals.
  • Evidence suggests potential benefits for aggressive behavior in non-epileptic patients, especially those with schizophrenia, warranting further investigation.
  • Doses of 600-1,200 mg/day showed good control, though relationships with blood levels and concurrent neuroleptic treatment require more study.

Impact:

  • Provides evidence for carbamazepine as a treatment option for aggression.
  • Highlights the need for further research, particularly double-blind studies, in broader patient populations.
  • Emphasizes the importance of monitoring for rare but serious side effects like bone marrow suppression and hepatotoxicity.

Related Experiment Videos